Join Dr. Mark Tarnopolsky, founder, CEO and CSO of Exerkine Corporation, a biotechnology/nutraceutical company developing therapies for aging, obesity, muscular dystrophy, and mitochondrial disorders, as he discusses aging as it […]
Expert Series: Molecular Bypass Deoxynucleoside Therapy for Thymidine Kinase 2 Deficiency (TK2d)Expert Series:
Thymidine kinase 2 deficiency (TK2d) is a rare mitochondrial disease due to mutations in the TK2 gene (TK2). Deficiency of TK2 enzyme causes depletion and multiple deletions of mitochondrial DNA […]
Pyruvate Dehydrogenase, Compassionate Use & Clinical Trials
This presentation will discuss lactic acidosis and focus on pyruvate dehydrogenase as a case study to explore how compassionate use and clinical trials can be used in patients with mitochondrial […]
Finding the sweet spot: diagnosis and management of diabetes mellitus and hypoglycemia in individuals with mitochondrial disorders
Individuals with mitochondrial disorders are at increased risk of developing both high blood sugars (diabetes mellitus) and low blood sugars (hypoglycemia). We will review considerations for diagnosis and management of […]
Mitochondria and Psychiatry
This presentation will cover the evidence that, at least for a subset of people with bipolar disorder, mitochondria may be dysregulated in the brain. Medications used for bipolar disorder can […]
- 1
- 2
- 3
- …
- 40
- Next Page »
